TSA-DC vaccine (Beijing Institute Of Genomics Chinese Academy Of Sciences)

N/A

Report date: 2025/03/20 09:45:45

Base Information

Drug NameTSA-DC vaccine (Beijing Institute Of Genomics Chinese Academy Of Sciences)

Drug Alias Namedendritic cell-specific antigen targeting vaccine (Beijing Institute Of Genomics Chinese Academy Of Sciences)

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsGastrointestinal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesBeijing Institute Of Genomics, Chinese Academy Of Sciences (National Center For Bioinformatics)

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Institute Of Genomics, Chinese Academy Of Sciences (National Center For Bioinformatics)

Inactive CompaniesN/A

Active IndicationsGastrointestinal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A